Federal prosecutors have accused the chief executive of Tricolor Auto Group of collecting a $6.25 million bonus just weeks before…
Read More
Justice After Chaos: Liverpool Parade Attacker Handed 21-Year-Plus Prison Sentence
A court has sentenced the driver who deliberately rammed a vehicle into crowds during a Liverpool football victory parade to…
Read More
Frozen Billions and a Political Fault Line: Why the EU Is Divided Over Using Russian Assets to Aid Ukraine
As the war in Ukraine drags on, a new and contentious battle is unfolding inside the European Union—this time over…
Read More
“Pay Up Now or Face the Courts”: Starmer Escalates Pressure on Abramovich Over Frozen Billions
British Prime Minister Keir Starmer has issued a stark warning to Russian billionaire Roman Abramovich, telling him to release billions…
Read More
Full List: Countries Affected by Trump’s Expanded U.S. Travel Ban
The United States has significantly widened its travel restrictions under an expanded policy announced by former President Donald Trump, bringing…
Read More
From Morning Swim to National Hero: Ahmed Al Ahmed’s Courage at Bondi Beach Sparks Over $1 Million in Public Support
A quiet day at Sydney’s iconic Bondi Beach turned into a moment of national reckoning when Ahmed Al Ahmed, an…
Read More
IV Vitamin Therapy: Health Boost or Overhyped Trend? Experts Say ‘Follow Your Gut’
IV vitamin therapy has surged in popularity over the past few years, with clinics and wellness centers touting direct intravenous…
Read More
New Research Suggests Mental Health Conditions May Share More in Common Than Previously Believed
Emerging research is challenging traditional classifications of mental health disorders, suggesting that many conditions—ranging from anxiety and depression to bipolar…
Read More
Revolutionary At-Home Device Targets Depression With Gentle Brain Stimulation
A new FDA-cleared at-home device is offering hope for millions of people struggling with depression, delivering gentle electrical stimulation to…
Read More
Blindness Lawsuits Target Ozempic and Other GLP-1 Drugs, Triggering Second Wave of Mass Litigation
A new wave of lawsuits has emerged against pharmaceutical companies producing GLP-1 receptor agonists, including Ozempic, alleging that the drugs…
Read More
